VUPANORSEN SODIUM
UNII X70RY8Q6LI

Substance Identification & Data

This profile provides standardized clinical and technical data for Vupanorsen Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X70RY8Q6LI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2172852-12-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X70RY8Q6LI

CAS Registry Number

2172852-12-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VUPANORSEN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174943

National Cancer Institute reference terminology for clinical and research data.

USAN ID

FG-168

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vupanorsen Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VUPANORSEN SODIUM

Common Names & Synonyms

VUPANORSEN SODIUM [USAN]

Systematic Nomenclature

DNA, D((2'-O-(2-METHOXYETHYL))RG-SP-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))RA-T-SP-T-SP-G-SP-M5C-SP-M5C-SP-A-SP-G-SP-T-SP-A-SP-A-SP-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))RG-SP-(2'-O-(2-METHOXYETHYL))M5RC-SP-(2'-O-(2-METHOXYETHYL))RA), 5'-(26-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-14,14-BIS((3-((6-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)HEXYL)AMINO)-3-OXOPROPOXY)METHYL)-8,12,19-TRIOXO-16-OXA-7,13,20-TRIAZAHEXACOS-1-YL HYDROGEN PHOSPHATE), SODIUM SALT (1:20)

SYS